Daptomycin use in mrsa bacteremia of a patient with myasthenia gravis: A case report

YĂĽkleniyor...
Küçük Resim

Tarih

2016

Dergi Başlığı

Dergi ISSN

Cilt Başlığı

Yayıncı

Erişim Hakkı

info:eu-repo/semantics/embargoedAccess

Ă–zet

Myasthenia gravis (MG) is the most common autoimmune disease affecting the neuromuscular junction and is characterized by ocular, bulbar, limb and respiratory muscle involvement. Some of the drugs may induce and exacerbate MG. Antibiotics are also one of the most important medication groups that may worsen MG and they should be used with caution in these patients with MG. Herein, we would like to share our experience about daptomycin use in Methicillin-resistant Staphylococcus aureus (MRSA) bacteremia of a patient with myasthenia gravis.

Açıklama

Anahtar Kelimeler

Myasthenia Gravis, Bacteremia, Daptomycin

Kaynak

Medicine Science

WoS Q DeÄźeri

Scopus Q DeÄźeri

Cilt

5

Sayı

Supplement 1

KĂĽnye

Arslan, B., Karagöz, E. ve Arslan, F. (2016). Daptomycin use in mrsa bacteremia of a patient with myasthenia gravis: A case report. Medicine Science, 5(Supplement1), 96-98.